Frazier Life Sciences VIII, L.P.
CIK 1655827 · last filed 2023-10-26
Frazier Life Sciences VIII, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider bought $1.0M of ARQT on Oct 26, 2023. Across all open-market trades the lifetime net is +$30.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $237.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$237.16M
2
3
$30.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | 10%+ Owner | 8,783,613 | $27.00 | $237.16M | $26.00M | 2 | 2023-10-26 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | 10%+ Owner | 1,484,115 | $64.97 | $96.42M | $4.00M | 1 | 2022-02-15 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-26 | ARQT | Buy (P) | +400,000 | $1.00M | EDGAR |
| 2022-08-09 | ARQT | Buy (P) | +1,250,000 | $25.00M | EDGAR |
| 2022-02-15 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Buy (P) | +563,325 | $4.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.